315 related articles for article (PubMed ID: 12165506)
1. Antigen-driven oligoclonal expansion of tumor-infiltrating B cells in infiltrating ductal carcinoma of the breast.
Coronella JA; Spier C; Welch M; Trevor KT; Stopeck AT; Villar H; Hersh EM
J Immunol; 2002 Aug; 169(4):1829-36. PubMed ID: 12165506
[TBL] [Abstract][Full Text] [Related]
2. Antigen-driven clonal proliferation, somatic hypermutation, and selection of B lymphocytes infiltrating human ductal breast carcinomas.
Nzula S; Going JJ; Stott DI
Cancer Res; 2003 Jun; 63(12):3275-80. PubMed ID: 12810659
[TBL] [Abstract][Full Text] [Related]
3. Tumor-infiltrating B cell immunoglobulin variable region gene usage in invasive ductal breast carcinoma.
Simsa P; Teillaud JL; Stott DI; Tóth J; Kotlan B
Pathol Oncol Res; 2005; 11(2):92-7. PubMed ID: 15999153
[TBL] [Abstract][Full Text] [Related]
4. Novel ganglioside antigen identified by B cells in human medullary breast carcinomas: the proof of principle concerning the tumor-infiltrating B lymphocytes.
Kotlan B; Simsa P; Teillaud JL; Fridman WH; Toth J; McKnight M; Glassy MC
J Immunol; 2005 Aug; 175(4):2278-85. PubMed ID: 16081796
[TBL] [Abstract][Full Text] [Related]
5. Antigen Specificity and Clinical Significance of IgG and IgA Autoantibodies Produced
Garaud S; Zayakin P; Buisseret L; Rulle U; Silina K; de Wind A; Van den Eyden G; Larsimont D; Willard-Gallo K; Linē A
Front Immunol; 2018; 9():2660. PubMed ID: 30515157
[TBL] [Abstract][Full Text] [Related]
6. Tumor specific cytolysis by tumor infiltrating lymphocytes in breast cancer.
Baxevanis CN; Dedoussis GV; Papadopoulos NG; Missitzis I; Stathopoulos GP; Papamichail M
Cancer; 1994 Aug; 74(4):1275-82. PubMed ID: 7914469
[TBL] [Abstract][Full Text] [Related]
7. Restoration of tumor-specific HLA class I restricted cytotoxicity in tumor infiltrating lymphocytes of advanced breast cancer patients by in vitro stimulation with tumor antigen-pulsed autologous dendritic cells.
Kass R; Bellone S; Palmieri M; Canè S; Bignotti E; Henry-Tillman R; Hutchins L; Cannon MJ; Klimberg S; Santin AD
Breast Cancer Res Treat; 2003 Aug; 80(3):275-85. PubMed ID: 14503800
[TBL] [Abstract][Full Text] [Related]
8. Evidence for an antigen-driven humoral immune response in medullary ductal breast cancer.
Coronella JA; Telleman P; Kingsbury GA; Truong TD; Hays S; Junghans RP
Cancer Res; 2001 Nov; 61(21):7889-99. PubMed ID: 11691809
[TBL] [Abstract][Full Text] [Related]
9. Translocation of an intracellular antigen to the surface of medullary breast cancer cells early in apoptosis allows for an antigen-driven antibody response elicited by tumor-infiltrating B cells.
Hansen MH; Nielsen HV; Ditzel HJ
J Immunol; 2002 Sep; 169(5):2701-11. PubMed ID: 12193744
[TBL] [Abstract][Full Text] [Related]
10. Is the tumor infiltrating natural killer cell (NK-TILs) count in infiltrating ductal carcinoma of breast prognostically significant?
Rathore AS; Goel MM; Makker A; Kumar S; Srivastava AN
Asian Pac J Cancer Prev; 2014; 15(8):3757-61. PubMed ID: 24870789
[TBL] [Abstract][Full Text] [Related]
11. Tumor-Infiltrating B Lymphocyte Profiling Identifies IgG-Biased, Clonally Expanded Prognostic Phenotypes in Triple-Negative Breast Cancer.
Harris RJ; Cheung A; Ng JCF; Laddach R; Chenoweth AM; Crescioli S; Fittall M; Dominguez-Rodriguez D; Roberts J; Levi D; Liu F; Alberts E; Quist J; Santaolalla A; Pinder SE; Gillett C; Hammar N; Irshad S; Van Hemelrijck M; Dunn-Walters DK; Fraternali F; Spicer JF; Lacy KE; Tsoka S; Grigoriadis A; Tutt ANJ; Karagiannis SN
Cancer Res; 2021 Aug; 81(16):4290-4304. PubMed ID: 34224371
[TBL] [Abstract][Full Text] [Related]
12. Prognostic significance of tumour infiltrating B lymphocytes in breast ductal carcinoma in situ.
Miligy I; Mohan P; Gaber A; Aleskandarany MA; Nolan CC; Diez-Rodriguez M; Mukherjee A; Chapman C; Ellis IO; Green AR; Rakha EA
Histopathology; 2017 Aug; 71(2):258-268. PubMed ID: 28326600
[TBL] [Abstract][Full Text] [Related]
13. The tumor-infiltrating B cell response in medullary breast cancer is oligoclonal and directed against the autoantigen actin exposed on the surface of apoptotic cancer cells.
Hansen MH; Nielsen H; Ditzel HJ
Proc Natl Acad Sci U S A; 2001 Oct; 98(22):12659-64. PubMed ID: 11606714
[TBL] [Abstract][Full Text] [Related]
14. Identification of tumor-binding scFv derived from clonally related B cells in tumor and lymph node of a patient with breast cancer.
Novinger LJ; Ashikaga T; Krag DN
Cancer Immunol Immunother; 2015 Jan; 64(1):29-39. PubMed ID: 25261355
[TBL] [Abstract][Full Text] [Related]
15. Tumor-Associated Disialylated Glycosphingolipid Antigen-Revealing Antibodies Found in Melanoma Patients' Immunoglobulin Repertoire Suggest a Two-Direction Regulation Mechanism Between Immune B Cells and the Tumor.
Kotlan B; Horvath S; Eles K; Plotar VK; Naszados G; Czirbesz K; Blank M; Farkas E; Toth L; Tovari J; Szekacs A; Shoenfeld Y; Godeny M; Kasler M; Liszkay G
Front Immunol; 2019; 10():650. PubMed ID: 31024530
[TBL] [Abstract][Full Text] [Related]
16. T cell receptor (TCR) structure of autologous melanoma-reactive cytotoxic T lymphocyte (CTL) clones: tumor-infiltrating lymphocytes overexpress in vivo the TCR beta chain sequence used by an HLA-A2-restricted and melanocyte-lineage-specific CTL clone.
Sensi M; Salvi S; Castelli C; Maccalli C; Mazzocchi A; Mortarini R; Nicolini G; Herlyn M; Parmiani G; Anichini A
J Exp Med; 1993 Oct; 178(4):1231-46. PubMed ID: 8376931
[TBL] [Abstract][Full Text] [Related]
17. Tumor infiltrating B-cells signal functional humoral immune responses in breast cancer.
Garaud S; Buisseret L; Solinas C; Gu-Trantien C; de Wind A; Van den Eynden G; Naveaux C; Lodewyckx JN; Boisson A; Duvillier H; Craciun L; Ameye L; Veys I; Paesmans M; Larsimont D; Piccart-Gebhart M; Willard-Gallo K
JCI Insight; 2019 Aug; 5(18):. PubMed ID: 31408436
[TBL] [Abstract][Full Text] [Related]
18. Characterization of lymphocytes infiltrating human breast cancer: specific immune reactivity detected by measuring cytokine secretion.
Schwartzentruber DJ; Solomon D; Rosenberg SA; Topalian SL
J Immunother (1991); 1992 Jul; 12(1):1-12. PubMed ID: 1637779
[TBL] [Abstract][Full Text] [Related]
19. Presence of CD3+ tumor infiltrating lymphocytes is significantly associated with good prognosis in infiltrating ductal carcinoma of breast.
Rathore AS; Kumar S; Konwar R; Srivastava AN; Makker A; Goel MM
Indian J Cancer; 2013; 50(3):239-44. PubMed ID: 24061465
[TBL] [Abstract][Full Text] [Related]
20. Analysis of tumour-infiltrating lymphocytes reveals two new biologically different subgroups of breast ductal carcinoma in situ.
Beguinot M; Dauplat MM; Kwiatkowski F; Lebouedec G; Tixier L; Pomel C; Penault-Llorca F; Radosevic-Robin N
BMC Cancer; 2018 Feb; 18(1):129. PubMed ID: 29394917
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
